Alpine Global Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Alpine Global Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-7,500	Closed	-$295K	–	278
2023 Q2	$295K	Buy	+7,500	New	+$265K	0.08%	131
2022 Q1	–	Sell	-90,093	Closed	-$1.51M	–	798
2021 Q4	$1.51M	Buy	+90,093	New	+$1.48M	0.22%	87
2021 Q1	–	Sell	-16,520	Closed	-$114K	–	385
2020 Q4	$114K	Buy	+16,520	New	+$106K	0.02%	152
2020 Q1	–	Sell	-17,628	Closed	-$151K	–	480
2019 Q4	$151K	Buy	+17,628	New	+$63K	0.03%	337

Alpine Global Management's ISEE Position: Q3 2023 in Review

Alpine Global Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 7,500 shares — an estimated $295K sold.

Alpine Global Management first reported a position in ISEE in Q4 2019 and held it in 4 quarters. The position peaked at $1.51M in Q4 2021. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Alpine Global Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Alpine Global Management sold 7,500 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $295K.
Alpine Global Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
Alpine Global Management's IVERIC bio, Inc. Common Stock position peaked at $1.51M in Q4 2021.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Alpine Global Management's 13F filing for Q3 2023, filed 14 Nov 2023.